FDA denies expanded Avodart OK for now -Glaxo | Reuters

Links shared publicly online about this topic.

  • 551
    total visits

FDA denies expanded Avodart OK for now -Glaxo | Reuters

reuters.com

NEW YORK (Reuters) - U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the British

View full resource at reuters.com

Tags: Prostate, Benign Prostatic Hypertrophy Medication, Healthy Living, Men's Health, FDA, Avodart, GlaxoSmithKline, Enlarged Prostate

  • Share

Most Recently Shared on January 27, 2011 at 3:49 am By:

Bradmed Brad Lipson, DO

FDA denies expanded Avodart OK for now -Glaxo: NEW YORK (Reuters) - U.S. health regulators declined to app... http://tinyurl.com/4bgtyul

1 year ago...

Advertisement